The Biotech Growth Trust PLC (the “Company”)
Compliance with Market Abuse Regulation
12 May 2023
The Company confirms that:
a) all inside information which the Directors and Company may
have had has been notified to a Regulated Information Service (“RIS”);
b) the Company’s net asset value per share is calculated and
announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any
material difference between the net asset value per share as at close of
business on Friday, 31 March 2023, which was announced on Monday, 3 April
2023, and the financial information to be published in the announcement of its
results for the year ended 31 March 2023.
The Company is, therefore, not prohibited from dealing in its own securities
during the closed period, as defined by the UK Market Abuse Regulation, which
will end on the date of the publication of its results for the year ended 31
March 2023, expected to be on or after Thursday, 15 June 2023.
-ENDS-
For further information please contact:
Katherine Manson Frostrow Capital LLP - 0203 709 8734
Copyright (c) 2023 PR Newswire Association,LLC. All Rights Reserved